121 related articles for article (PubMed ID: 26549027)
1. Cytoplasmic PML promotes TGF-β-associated epithelial-mesenchymal transition and invasion in prostate cancer.
Buczek ME; Miles AK; Green W; Johnson C; Boocock DJ; Pockley AG; Rees RC; Hulman G; van Schalkwyk G; Parkinson R; Hulman J; Powe DG; Regad T
Oncogene; 2016 Jun; 35(26):3465-75. PubMed ID: 26549027
[TBL] [Abstract][Full Text] [Related]
2. Potent Inhibition of miR-34b on Migration and Invasion in Metastatic Prostate Cancer Cells by Regulating the TGF-β Pathway.
Fang LL; Sun BF; Huang LR; Yuan HB; Zhang S; Chen J; Yu ZJ; Luo H
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29257105
[TBL] [Abstract][Full Text] [Related]
3. TR4 nuclear receptor increases prostate cancer invasion via decreasing the miR-373-3p expression to alter TGFβR2/p-Smad3 signals.
Qiu X; Zhu J; Sun Y; Fan K; Yang DR; Li G; Yang G; Chang C
Oncotarget; 2015 Jun; 6(17):15397-409. PubMed ID: 25980442
[TBL] [Abstract][Full Text] [Related]
4. DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transition.
Chen N; Balasenthil S; Reuther J; Frayna A; Wang Y; Chandler DS; Abruzzo LV; Rashid A; Rodriguez J; Lozano G; Cao Y; Lokken E; Chen J; Frazier ML; Sahin AA; Wistuba II; Sen S; Lott ST; Killary AM
Cancer Discov; 2013 Oct; 3(10):1172-89. PubMed ID: 23838884
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk of protein kinase C ε with Smad2/3 promotes tumor cell proliferation in prostate cancer cells by enhancing aerobic glycolysis.
Xu W; Zeng F; Li S; Li G; Lai X; Wang QJ; Deng F
Cell Mol Life Sci; 2018 Dec; 75(24):4583-4598. PubMed ID: 30209539
[TBL] [Abstract][Full Text] [Related]
6. PPM1A dephosphorylates RanBP3 to enable efficient nuclear export of Smad2 and Smad3.
Dai F; Shen T; Li Z; Lin X; Feng XH
EMBO Rep; 2011 Oct; 12(11):1175-81. PubMed ID: 21960005
[TBL] [Abstract][Full Text] [Related]
7. TGFβ signaling limits lineage plasticity in prostate cancer.
Hao Y; Bjerke GA; Pietrzak K; Melhuish TA; Han Y; Turner SD; Frierson HF; Wotton D
PLoS Genet; 2018 May; 14(5):e1007409. PubMed ID: 29782499
[TBL] [Abstract][Full Text] [Related]
8. The Dynamics of TGF-β Signaling Are Dictated by Receptor Trafficking via the ESCRT Machinery.
Miller DSJ; Bloxham RD; Jiang M; Gori I; Saunders RE; Das D; Chakravarty P; Howell M; Hill CS
Cell Rep; 2018 Nov; 25(7):1841-1855.e5. PubMed ID: 30428352
[TBL] [Abstract][Full Text] [Related]
9. Cofilin drives cell-invasive and metastatic responses to TGF-β in prostate cancer.
Collazo J; Zhu B; Larkin S; Martin SK; Pu H; Horbinski C; Koochekpour S; Kyprianou N
Cancer Res; 2014 Apr; 74(8):2362-73. PubMed ID: 24509905
[TBL] [Abstract][Full Text] [Related]
10. Promyelocytic leukemia protein regulates angiogenesis and epithelial-mesenchymal transition to limit metastasis in MDA-MB-231 breast cancer cells.
Vogiatzoglou AP; Spanou S; Sachini N; Drakos E; Nikolaou C; Makatounakis T; Kretsovali A; Papamatheakis J
Mol Oncol; 2023 Oct; 17(10):2090-2108. PubMed ID: 37518985
[TBL] [Abstract][Full Text] [Related]
11. The STK38-XPO1 axis, a new actor in physiology and cancer.
Martin AP; Aushev VN; Zalcman G; Camonis JH
Cell Mol Life Sci; 2021 Mar; 78(5):1943-1955. PubMed ID: 33145612
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-β and the hallmarks of cancer.
Tian M; Neil JR; Schiemann WP
Cell Signal; 2011 Jun; 23(6):951-62. PubMed ID: 20940046
[TBL] [Abstract][Full Text] [Related]
13. TGF-β induces matrisome pathological alterations and EMT in patient-derived prostate cancer tumoroids.
Fernandes S; Oliver-De La Cruz J; Morazzo S; Niro F; Cassani M; Ďuríková H; Caravella A; Fiore P; Azzato G; De Marco G; Lauria A; Izzi V; Bosáková V; Fric J; Filipensky P; Forte G
Matrix Biol; 2024 Jan; 125():12-30. PubMed ID: 37944712
[TBL] [Abstract][Full Text] [Related]
14. A Genuinely Hybrid, Multiscale 3D Cancer Invasion and Metastasis Modelling Framework.
Katsaounis D; Harbour N; Williams T; Chaplain MA; Sfakianakis N
Bull Math Biol; 2024 Apr; 86(6):64. PubMed ID: 38664343
[TBL] [Abstract][Full Text] [Related]
15. Invasive cells follow Snail's slow and persistent pace.
García de Herreros A; Moustakas A
Cell Cycle; 2014; 13(15):2320-1. PubMed ID: 25483180
[No Abstract] [Full Text] [Related]
16. Characterization of KLHL14 anti-oncogenic action in malignant mesothelioma.
Canciello A; Domínguez RB; Barboni B; Giordano A; Morrione A
Heliyon; 2024 Mar; 10(6):e27731. PubMed ID: 38509883
[TBL] [Abstract][Full Text] [Related]
17. Correction: MKRN1 promotes colorectal cancer metastasis by activating the TGF-β signalling pathway through SNIP1 protein degradation.
Zhang Y; Li Q; Liu H; Tang H; Yang H; Wu D; Huang Y; Li L; Liu L; Li M
J Exp Clin Cancer Res; 2023 Sep; 42(1):240. PubMed ID: 37710340
[No Abstract] [Full Text] [Related]
18. Epithelial-mesenchymal transition in prostatic disease.
Broster SA; Kyprianou N
Future Oncol; 2015; 11(23):3197-206. PubMed ID: 26551285
[TBL] [Abstract][Full Text] [Related]
19. Kindlin-2 promotes invasiveness of prostate cancer cells via NF-κB-dependent upregulation of matrix metalloproteinases.
Yang JR; Pan TJ; Yang H; Wang T; Liu W; Liu B; Qian WH
Gene; 2016 Jan; 576(1 Pt 3):571-6. PubMed ID: 26551397
[TBL] [Abstract][Full Text] [Related]
20. Prostate specific G protein coupled receptor is associated with prostate cancer prognosis and affects cancer cell proliferation and invasion.
Cao W; Li F; Yao J; Yu J
BMC Cancer; 2015 Nov; 15():915. PubMed ID: 26582057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
